Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene
- PMID: 11593033
- PMCID: PMC59787
- DOI: 10.1073/pnas.211191098
Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) is characterized by cyst formation in the kidney, liver, and pancreas and is associated often with cardiovascular abnormalities such as hypertension, mitral valve prolapse, and intracranial aneurysms. It is caused by mutations in PKD1 or PKD2, encoding polycystin-1 and -2, which together form a cell surface nonselective cation ion channel. Pkd2-/- mice have cysts in the kidney and pancreas and defects in cardiac septation, whereas Pkd1(del34) -/- and Pkd1(L) -/- mice have cysts but no cardiac abnormalities, although vascular fragility was reported in the latter. Here we describe mice carrying a targeted mutation in Pkd1 (Pkd1(del17-21betageo)), which defines its expression pattern by using a lacZ reporter gene and may identify novel functions for polycystin-1. Although Pkd1(del17-21betageo) +/- adult mice develop renal and hepatic cysts, Pkd1(del17-21betageo) -/- embryos die at embryonic days 13.5-14.5 from a primary cardiovascular defect that includes double outflow right ventricle, disorganized myocardium, and abnormal atrio-ventricular septation. Skeletal development is also severely compromised. These abnormalities correlate with the major sites of Pkd1 expression. During nephrogenesis, Pkd1 is expressed in maturing tubular epithelial cells from embryonic day 15.5. This expression coincides with the onset of cyst formation in Pkd1(del34) -/-, Pkd1(L) -/-, and Pkd2-/- mice, supporting the hypothesis that polycystin-1 and polycystin-2 interact in vivo and that their failure to do so leads to abnormalities in tubule morphology and function.
Figures





Similar articles
-
Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation.Nat Genet. 1997 Oct;17(2):179-81. doi: 10.1038/ng1097-179. Nat Genet. 1997. PMID: 9326937
-
Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.Hum Mol Genet. 2006 Dec 15;15(24):3520-8. doi: 10.1093/hmg/ddl428. Epub 2006 Nov 2. Hum Mol Genet. 2006. PMID: 17082250
-
Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).Eur J Hum Genet. 2004 May;12(5):347-54. doi: 10.1038/sj.ejhg.5201162. Eur J Hum Genet. 2004. PMID: 14872199 Review.
-
Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.Hum Mol Genet. 2004 Dec 15;13(24):3069-77. doi: 10.1093/hmg/ddh336. Epub 2004 Oct 20. Hum Mol Genet. 2004. PMID: 15496422
-
[Pathogenesis of cystic kidney diseases].Verh Dtsch Ges Pathol. 2002;86:138-44. Verh Dtsch Ges Pathol. 2002. PMID: 12647363 Review. German.
Cited by
-
Pkd2 mesenteric vessels exhibit a primary defect in endothelium-dependent vasodilatation restored by rosiglitazone.Am J Physiol Heart Circ Physiol. 2013 Jan 1;304(1):H33-41. doi: 10.1152/ajpheart.01102.2011. Epub 2012 Oct 26. Am J Physiol Heart Circ Physiol. 2013. PMID: 23103499 Free PMC article.
-
Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.J Clin Invest. 2015 Feb;125(2):607-20. doi: 10.1172/JCI76972. Epub 2015 Jan 9. J Clin Invest. 2015. PMID: 25574838 Free PMC article.
-
Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure.Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18688-93. doi: 10.1073/pnas.0708217104. Epub 2007 Nov 14. Proc Natl Acad Sci U S A. 2007. PMID: 18003909 Free PMC article.
-
Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors.Hum Mol Genet. 2006 Jan 1;15(1):11-21. doi: 10.1093/hmg/ddi421. Epub 2005 Nov 21. Hum Mol Genet. 2006. PMID: 16301212 Free PMC article.
-
ADPKD: molecular characterization and quest for treatment.Clin Exp Nephrol. 2005 Dec;9(4):282-291. doi: 10.1007/s10157-005-0367-6. Clin Exp Nephrol. 2005. PMID: 16362154 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous